HC Wainwright Estimates Quantum-Si FY2029 Earnings

Quantum-Si incorporated (NASDAQ:QSIFree Report) – Equities research analysts at HC Wainwright issued their FY2029 earnings per share estimates for Quantum-Si in a research report issued on Tuesday, March 4th. HC Wainwright analyst S. Ramakanth anticipates that the company will post earnings of $0.23 per share for the year. HC Wainwright currently has a “Buy” rating and a $5.50 price target on the stock. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share.

Other equities analysts also recently issued research reports about the stock. Alliance Global Partners initiated coverage on shares of Quantum-Si in a research note on Friday, February 7th. They set a “buy” rating and a $3.75 target price for the company. Canaccord Genuity Group lowered their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, November 13th.

Read Our Latest Analysis on QSI

Quantum-Si Stock Performance

Quantum-Si stock opened at $1.38 on Wednesday. The firm has a 50 day moving average price of $2.24 and a two-hundred day moving average price of $1.45. Quantum-Si has a 52-week low of $0.61 and a 52-week high of $5.77. The firm has a market cap of $196.94 million, a price-to-earnings ratio of -2.16 and a beta of 2.69.

Insider Transactions at Quantum-Si

In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of the stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $3.34, for a total value of $11,710,931.78. Following the transaction, the director now owns 1,250,000 shares in the company, valued at approximately $4,175,000. This represents a 73.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 30.04% of the company’s stock.

Institutional Investors Weigh In On Quantum-Si

A number of institutional investors and hedge funds have recently bought and sold shares of QSI. Wolverine Asset Management LLC bought a new stake in Quantum-Si in the 4th quarter worth about $26,000. Abel Hall LLC purchased a new position in shares of Quantum-Si in the 4th quarter worth approximately $28,000. Dudley Capital Management LLC purchased a new position in shares of Quantum-Si in the 4th quarter worth approximately $30,000. Jump Financial LLC bought a new position in shares of Quantum-Si in the fourth quarter valued at approximately $33,000. Finally, Cetera Investment Advisers bought a new position in Quantum-Si during the fourth quarter valued at about $36,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

(Get Free Report)

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.

Recommended Stories

Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.